タブレクタ錠の特定使用成績調査

基本情報

NCT ID

NCT04575025

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

109

治験依頼者名

Novartis

概要

This study was an uncontrolled, primary data collection-based observational study to be conducted as a central registration system, multicenter special drug-use results surveillance. As an all-case study, this study collected all patients treated with Tabrecta in a specified post-marketing period. The observation period of each patient was up to 1 year (52 weeks)

対象疾患

介入

依頼者（Sponsor）